BhuvanaAnanthaSettyMD

Pediatric Hematology & Oncology • Columbus, OH

Assistant Professor, Pediatrics, Ohio State University College of Medicine

Join to view full profile

Dr. Setty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Setty's full profile

Already have an account?

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-2000

Fax+1 614-722-3699

Education & Training

Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2005 - 2008
BLDE University - Medical CollegeClass of 2004

Certifications & Licensure

OH State Medical License 2008 - 2026
IL State Medical License 2005 - 2008
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma.
Stephanie Fetzko, Abha A Gupta, Bhuvana A Setty, Mary Wedekind Malone, Jeremy Schraw
Pediatric Blood & Cancer. 2025-03-01
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...
Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02
2 citations
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients.
Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B Chakravarthy, Thomas Scharschmidt
Cancers. 2024-05-30

Press Mentions

Salarius Pharmaceuticals Adds Memorial Sloan Kettering Cancer Center and Nationwide Children’s Hospital as Clinical Sites for Phase 1/2 Trial of Seclidemstat in Ewing SarcomaOctober 8th, 2019
Girl's Documentation of Battle with Cancer Aims to Give Hope to OthersDecember 13th, 2018
Local Researchers Studying NK Cells' Ability to Fight CancerMarch 18th, 2021